Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Purdie

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.
Journal of Rehabilitation Medicine|April 15, 2021
Post-intensive care syndrome following cardiothoracic critical care: Feasibility of a complex interventionPhilip Henderson, Tara Quasim, Annette Asher, et al.
Annals of the American Thoracic Society|July 28, 2020
Medication-related Problems in Intensive Care Unit Survivors: Learning from a Multicenter ProgramPamela MacTavish, Tara Quasim, Colin Purdie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
British Journal of Cancer|March 25, 2021
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) casesEmad A Rakha, Islam M Miligy, Cecily M Quinn, et al.
Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Nature Communications|July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancerHa-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Breast Cancer Research and Treatment|June 10, 2011
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trialSirwan Hadad, Takayuki Iwamoto, Lee Jordan, et al.
Journal of Rehabilitation Medicine|April 15, 2021
Post-intensive care syndrome following cardiothoracic critical care: Feasibility of a complex interventionPhilip Henderson, Tara Quasim, Annette Asher, et al.
Annals of the American Thoracic Society|July 28, 2020
Medication-related Problems in Intensive Care Unit Survivors: Learning from a Multicenter ProgramPamela MacTavish, Tara Quasim, Colin Purdie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2021
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancerAyaka Katayama, Islam M Miligy, Sho Shiino, et al.
British Journal of Cancer|March 25, 2021
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) casesEmad A Rakha, Islam M Miligy, Cecily M Quinn, et al.
Nature Communications|September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltrationMarcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Nature Communications|July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancerHa-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
Pageof 2